Table 2: OSTI-2483 Trypsin Ki = 0.131 μM
- Measure
- Ki
- Value
- 0.131 µM
- Target
- trypsin
- Assay
- Not reported by source
Biomolecules · 2026
Sequence evidence
VKWKVKWKCWTKSKPPKPCKNH
Table 1: OSTI-2483 sequence VKWKVKWKCWTKSKPPKPCK-NH2
Experimental observations
Table 2: OSTI-2483 Trypsin Ki = 0.131 μM
Table 3: OSTI-2483 MIC 4 μM against E. coli ATCC CRM 8739
Table 3: OSTI-2483 MBC 4 μM against E. coli ATCC CRM 8739
Table 3: OSTI-2483 MIC 8 μM against E. coli BAA 2340
Table 3: OSTI-2483 MBC 8 μM against E. coli BAA 2340
Table 3: OSTI-2483 MIC 4 μM against E. coli NCTC 13846
Table 3: OSTI-2483 MBC 4 μM against E. coli NCTC 13846
Table 3: OSTI-2483 MIC 8 μM against P. aeruginosa ATCC CRM 9027
Table 3: OSTI-2483 MBC 16 μM against P. aeruginosa ATCC CRM 9027
Table 3: OSTI-2483 MIC 64 μM against K. pneumoniae ATCC CRM 43861
Table 3: OSTI-2483 MBC 64 μM against K. pneumoniae ATCC CRM 43861
Table 3: OSTI-2483 MIC 128 μM against A. baumannii BAA 747
Table 3: OSTI-2483 MBC 128 μM against A. baumannii BAA 747
Table 3: OSTI-2483 MIC 512 μM against S. aureus ATCC CRM 6538
Table 3: OSTI-2483 MBC 512 μM against S. aureus ATCC CRM 6538
Table 3: OSTI-2483 MIC >512 μM against E. faecium NCTC 12697
Table 3: OSTI-2483 MIC 8 μM against MRSA NCTC 12493
Table 3: OSTI-2483 MBC 8 μM against MRSA NCTC 12493
Table 3: OSTI-2483 MIC >512 μM against C. albicans ATCC 10231
Section 3.8: OSTI-2483 produced little haemolysis, less than 10% even at the highest concentrations (1-512 μM) against horse erythrocytes
Section 3.8: OSTI-2483 had minimal impact on HaCaT cell proliferation at 0.1-10 μM but reduced proliferation by more than 20% at 100 μM
Table 4: OSTI-2483 MIC 4 μM against E. coli ATCC CRM 8739 in 1% DMSO (control)
Table 4: OSTI-2483 MBC 4 μM against E. coli ATCC CRM 8739 in 1% DMSO (control)
Table 4: OSTI-2483 MIC 4 μM against E. coli ATCC CRM 8739 with FeCl3
Table 4: OSTI-2483 MBC 4 μM against E. coli ATCC CRM 8739 with FeCl3
Table 4: OSTI-2483 MIC 8 μM against E. coli ATCC CRM 8739 with CaCl2
Table 4: OSTI-2483 MBC 8 μM against E. coli ATCC CRM 8739 with CaCl2
Table 4: OSTI-2483 MIC 8 μM against E. coli ATCC CRM 8739 with NaCl
Table 4: OSTI-2483 MBC 8 μM against E. coli ATCC CRM 8739 with NaCl
Table 4: OSTI-2483 MIC 4 μM against E. coli ATCC CRM 8739 with KCl
Table 4: OSTI-2483 MBC 4 μM against E. coli ATCC CRM 8739 with KCl
Table 4: OSTI-2483 MIC 8 μM against E. coli ATCC CRM 8739 with MgCl2
Table 4: OSTI-2483 MBC 8 μM against E. coli ATCC CRM 8739 with MgCl2
Table 4: OSTI-2483 MIC 4 μM against E. coli ATCC CRM 8739 with NH4Cl
Table 4: OSTI-2483 MBC 4 μM against E. coli ATCC CRM 8739 with NH4Cl
Table 4: OSTI-2483 MIC 4 μM against E. coli ATCC CRM 8739 with Serum
Table 4: OSTI-2483 MBC 8 μM against E. coli ATCC CRM 8739 with Serum
Table 5: OSTI-2483 MIC 4 μM against E. coli ATCC CRM 8739 (Contrast)
Table 5: OSTI-2483 MBC 4 μM against E. coli ATCC CRM 8739 (Contrast)
Table 5: OSTI-2483 MIC 4 μM against E. coli ATCC CRM 8739 with 0.25 mg/mL trypsin
Table 5: OSTI-2483 MBC 4 μM against E. coli ATCC CRM 8739 with 0.25 mg/mL trypsin
Table 5: OSTI-2483 MIC 8 μM against E. coli ATCC CRM 8739 with 0.5 mg/mL trypsin
Table 5: OSTI-2483 MBC 16 μM against E. coli ATCC CRM 8739 with 0.5 mg/mL trypsin
Local peptide labels such as P1, PEP1, or peptide 1 are grouped only within this paper and are not assumed to represent the same molecule across publications.